Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What is clinically relevant weight loss for your patients and how can it be achieved? A narrative review
Deborah B. Horn, Jaime P. Almandoz, Michelle Look
Postgraduate Medicine (2022) Vol. 134, Iss. 4, pp. 359-375
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
Vanita R. Aroda, Jens Aberle, Lars Bardtrum, et al.
The Lancet (2023) Vol. 402, Iss. 10403, pp. 693-704
Open Access | Times Cited: 62
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
Yiming Mu, Xiao-lei Bao, Freddy G. Eliaschewitz, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 3, pp. 184-195
Closed Access | Times Cited: 40
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
Barbara McGowan, Jens Meldgaard Bruun, Matt Capehorn, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 9, pp. 631-642
Closed Access | Times Cited: 24
Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial
Emilie Combet, Laura Haag, Janice Richardson, et al.
Nature Medicine (2025)
Open Access | Times Cited: 2
Long‐Term Weight Loss Outcomes in a Virtual Weight Care Clinic Prescribing a Broad Range of Medications Alongside Behavior Change
Jennifer M. Clark, Brooke J. Smith, Jessie Juusola, et al.
Obesity Science & Practice (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
An overview of obesity‐related complications: The epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes
Matthias Blüher
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 2
Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus
Oluwaseun Anyiam, Bethan E. Phillips, Katie Quinn, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 8, pp. 1907-1913
Open Access | Times Cited: 9
Effectiveness of an Email-Based, Semaglutide-Supported Weight-Loss Service for People with Overweight and Obesity in Germany: A Real-World Retrospective Cohort Analysis
Louis Talay, Matt Vickers, Laura Ruiz
Obesities (2024) Vol. 4, Iss. 3, pp. 256-269
Open Access | Times Cited: 7
Effects of a Web-Based Lifestyle Intervention on Weight Loss and Cardiometabolic Risk Factors in Adults With Overweight and Obesity: Randomized Controlled Clinical Trial
Jan Kohl, Judith Brame, Christoph Centner, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e43426-e43426
Open Access | Times Cited: 13
Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-Making
Kimberly A. Gudzune, Lee M. Kaplan, Scott Kahan, et al.
Endocrine Practice (2024) Vol. 30, Iss. 10, pp. 917-926
Open Access | Times Cited: 4
Assessing the evidence for health benefits of low-level weight loss: a systematic review
Dipok Kumar Dhar, Jessica Packer, Semina Michalopoulou, et al.
International Journal of Obesity (2024) Vol. 49, Iss. 2, pp. 254-268
Open Access | Times Cited: 4
Assessment of the Potential Clinical and Economic Impact of Weight Loss in the Adult Population with Obesity and Associated Comorbidities in Spain
María D. Ballesteros‐Pomar, Ened Rodríguez-Urgellés, Miquel Sastre-Belío, et al.
Advances in Therapy (2025) Vol. 42, Iss. 2, pp. 1265-1282
Open Access
Determinants of adherence to obesity medication: A narrative review
Arya M. Sharma, Susie Birney, Michael Crotty, et al.
Obesity Reviews (2025)
Open Access
Effect of self-paced sprint interval training and low-volume HIIT on cardiorespiratory fitness: the role of heart rate and power output
Katie Hesketh, Sam O. Shepherd, Anton J. M. Wagenmakers, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
Obesity drives dysregulation in DC responses to viral infection
Andrea Woodcock, Ronan Bergin, Nidhi Kedia-Mehta, et al.
Discovery Immunology (2025) Vol. 4, Iss. 1
Open Access
Real‐world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® database
Theresa Hunter, Chanadda Chinthammit, Jennifer M. Ward, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
The application of metaverse in mental health
Yue Wang, Baoyan Duan, Xi Chen, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
How Increasing Adiposity Impacts Communicable Disease Risk at a Global and a Cellular Level
Andrea Woodcock, Féaron C. Cassidy
IntechOpen eBooks (2025)
Closed Access
A structured, home-based exercise programme in kidney transplant recipients (ECSERT): A randomised controlled feasibility study
Roseanne E. Billany, Jamie Macdonald, Stephanie Burns, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316031-e0316031
Open Access
Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison
Emily R. Hankosky, Xuanyao He, Raleigh Malik, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Factors associated with weight loss and health gains in a structured lifestyle modification programme for adults with severe obesity: a prospective cohort study
Francis Finucane, Irene Gibson, Robert Hughes, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Does Preoperative Weight Loss Within 6 Months or 1 Year Change the Risk of Adverse Outcomes in Total Knee Arthroplasty by Initial Body Mass Index Classification?
Albert J. Rechenmacher, William S. Yancy, Michael P. Bolognesi, et al.
The Journal of Arthroplasty (2023) Vol. 38, Iss. 12, pp. 2517-2522.e2
Closed Access | Times Cited: 8
Meal Timing and Anthropometric and Metabolic Outcomes
H Y Liu, Ashley A. Eso, Nathan Cook, et al.
JAMA Network Open (2024) Vol. 7, Iss. 11, pp. e2442163-e2442163
Open Access | Times Cited: 3
Incretin-based therapies for the treatment of obesity-related diseases
Irene Caruso, Angelo Cignarelli, Gian Pio Sorice, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Weight gain following switch to integrase inhibitors from non-nucleoside reverse transcriptase or protease inhibitors in people living with HIV in the United States: analyses of electronic medical records and prescription claims
Jenny Tse, Girish Prajapati, Xiaohui Zhao, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 9, pp. 1237-1246
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top